Alliqua, Inc. has signed an agreement with INC Research to assist with its Phase I trials for the development of its transdermal pain patch. Richard Rosenblum, president of Alliqua, commented, “Contracting INC Research is yet another important step towards our first-in-man trial with respect to the development of our PHN pain patch. The experience that INC Research’s team brings to the table is invaluable, having been involved in development of multiple pain patch therapies on the m...